CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS FOR MALARIA DETECTION

Patent №

US 11,618,928

Granted

2023-04-04

Filed 2018

Owner

PRESIDENT AND FELLOWS OF HARVARD COLLEGE

+2 more

AI components

1

vision

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

15952132

The embodiments disclosed herein utilized RNA targeting effectors to provide a robust CRISPR-based diagnostic with attomolar sensitivity. Embodiments disclosed herein can detect broth DNA and RNA with comparable levels of sensitivity and can differentiate targets from non-targets based on single base pair differences. Moreover, the embodiments disclosed herein can be prepared in freeze-dried format for convenient distribution and point-of-care (POC) applications. Such embodiments are useful in multiple scenarios in human health including, for example, viral detection, bacterial strain typing, sensitive genotyping, and detection of disease-associated cell free DNA.

VisionC12Q 1/6888C12N 9/22C12N 15/11C12Q 1/6883C12N 15/113C12N 2310/16C12N 2310/20C12N 2310/3517+4 more

AI classification

Vision0.74
Natural language0.02
Machine learning0.00
Speech0.00
AI hardware0.00
Evolutionary computation0.00
Knowledge representation0.00
Planning0.00

Ownership

PRESIDENT AND FELLOWS OF HARVARD COLLEGE

assignment · 466520418

THE BROAD INSTITUTE, INC.

assignment · 466880498

MASSACHUSETTS INSTITUTE OF TECHNOLOGY

assignment · 466880498

Assignors

EARLY, ANGELA, ZHANG, FENG, GOOTENBERG, JONATHAN, ABUDAYYEH, OMAR

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC